FIELD: medicine.
SUBSTANCE: invention refers to dermatology, namely to evaluating the clinical effectiveness of treatment of prurigo. That is ensured by determining concentration of β-tryptase in venous blood serum on 10th day of treatment, and if its value is 45 mcg/l and more, the clinical effectiveness is considered to be low, and if the value is less than 45 mcg/l – as high.
EFFECT: invention provides simplification of research, as well as reduction of its duration.
1 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRURIGO SEVERITY PREDICTION BY BLOOD TRYPTASE CONCENTRATION DETERMINATION METHOD | 2019 |
|
RU2707181C1 |
| METHOD OF EVALUATING THE CLINICAL EFFECTIVENESS OF NUMMULAR MICROBIAL ECZEMA | 2018 |
|
RU2695071C1 |
| METHOD FOR EVALUATING THE EFFECTIVENESS OF A STANDARD THERAPY IN THE PATIENTS WITH NUMULAR MICROBIAL ECZEMA | 2019 |
|
RU2699369C1 |
| METHOD FOR PREDICTING THE TRANSITION OF MODERATELY SEVERE NUMMULAR MICROBIAL ECZEMA TO SEVERE ONE | 2018 |
|
RU2681656C1 |
| METHOD FOR EVALUATING THE EFFECTIVENESS OF TREATMENT OF TRICHOPHITIA IN CHILDREN | 2021 |
|
RU2765859C1 |
| METHOD FOR ESTIMATING THE EFFICIENCY OF STANDARD THERAPY AMONG PATIENTS WITH NUMULAR MICROBIAL ECZEMA | 2018 |
|
RU2677881C1 |
| METHOD FOR PREDICTING THE TRANSITION OF THE MEDIUM-HEAVY COURSE OF THE NUMMULAR MICROBIAL ECZEMA INTO THE SEVERE COURSE | 2019 |
|
RU2702236C1 |
| METHOD OF ASSESSING THE EFFECTIVENESS OF TRICHOPHYTOSIS TREATMENT | 2019 |
|
RU2714317C1 |
| METHOD FOR PREDICTING THE TRANSITION OF THE INFILTRATIVE FORM OF ZOOANTHROPONOUS TRICHOPHYTOSIS TO THE SUPPURATIVE FORM OF THE DISEASE IN CHILDREN | 2021 |
|
RU2763826C1 |
| METHOD FOR ASSESSING THE SEVERITY OF ATOPIC DERMATITIS IN CHILDREN BY OPTICAL COHERENCE TOMOGRAPHY | 2018 |
|
RU2692955C1 |
